Form 4: Tiziana Life Sciences CEO Reports Stock Transaction
Insider Transaction (Form 4)
Ivor Elrifi, Chief Executive Officer of Tiziana Life Sciences Ltd, reported multiple transactions in common stock on August 15, 2026.
Summary
- Option exercise/conversion: acquired 1,050,000 COMMON STOCK on August 15, 2026; holds 5,843,684 after (Indirect).
- Option exercise/conversion: disposed of 1,050,000 Restricted Stock Unit on August 15, 2026; holds 2,100,000 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Ivor Elrifi — Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-15 | Option exercise/conversion | COMMON STOCK | 1,050,000 | — | — | 5,843,684 |
| 2026-08-15 | Option exercise/conversion | Restricted Stock Unit | 1,050,000 | — | — | 2,100,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-15 | Option exercise/conversion (1,050,000 shares) |
| 2026-08-15 | Option exercise/conversion (1,050,000 shares) |
Keywords
insider transaction, Form 4, TLSA, Tiziana Life Sciences Ltd, neutral, Ivor Elrifi
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.